Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3	1.83e-05	53	215	6	GO:0016339
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	TRO PCDHB5 DSCAML1 L1CAM PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3 CELSR3	2.79e-05	187	215	10	GO:0007156
GeneOntologyBiologicalProcess	regulation of barbed-end actin filament capping	CFL1 MTPN WASHC2C	3.79e-05	7	215	3	GO:2000812
GeneOntologyCellularComponent	basement membrane collagen trimer	COL4A4 COL4A6 COL15A1	5.86e-05	8	216	3	GO:0098651
GeneOntologyCellularComponent	cell cortex	ARHGAP32 CFL1 DENND2B C2CD5 MICAL3 BSN EXOC7 FLNA FLNB CEP85 PARD3B EXOC2 UNC13A	1.36e-04	371	216	13	GO:0005938
GeneOntologyCellularComponent	somatodendritic compartment	CYBB PCSK2 ARHGAP32 CFL1 KIF1B DPYSL5 MPDZ ITGA1 DDC KCNB1 VPS13A TSC22D4 BSN AGAP2 VGF FLNA FLNB YBX1 PRSS12 ACAD9 DLGAP4 L1CAM DOCK10 APOB GRM8 TRIM3 CASK	1.74e-04	1228	216	27	GO:0036477
GeneOntologyCellularComponent	Flemming body	MICAL3 EXOC7 AGAP2 EXOC2	5.04e-04	36	216	4	GO:0090543
GeneOntologyCellularComponent	dendrite	CYBB PCSK2 ARHGAP32 CFL1 KIF1B DPYSL5 MPDZ KCNB1 TSC22D4 BSN AGAP2 FLNA YBX1 PRSS12 ACAD9 DLGAP4 L1CAM DOCK10 TRIM3 CASK	6.13e-04	858	216	20	GO:0030425
GeneOntologyCellularComponent	USH2 complex	PDZD7 ADGRV1	6.29e-04	4	216	2	GO:1990696
GeneOntologyCellularComponent	dendritic tree	CYBB PCSK2 ARHGAP32 CFL1 KIF1B DPYSL5 MPDZ KCNB1 TSC22D4 BSN AGAP2 FLNA YBX1 PRSS12 ACAD9 DLGAP4 L1CAM DOCK10 TRIM3 CASK	6.31e-04	860	216	20	GO:0097447
Domain	IG_FLMN	FLNA FLNB TRIM71 TRIM3	3.27e-06	10	213	4	SM00557
Domain	-	NID2 ELP1 TRIM71 NHLRC3 TRIM3 RGN	4.89e-06	39	213	6	2.120.10.30
Domain	Filamin	FLNA FLNB TRIM71 TRIM3	5.10e-06	11	213	4	PF00630
Domain	FILAMIN_REPEAT	FLNA FLNB TRIM71 TRIM3	5.10e-06	11	213	4	PS50194
Domain	Filamin/ABP280_repeat-like	FLNA FLNB TRIM71 TRIM3	5.10e-06	11	213	4	IPR017868
Domain	Filamin/ABP280_rpt	FLNA FLNB TRIM71 TRIM3	5.10e-06	11	213	4	IPR001298
Domain	Cadherin_C	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3	7.64e-06	42	213	6	IPR032455
Domain	Cadherin_C_2	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3	7.64e-06	42	213	6	PF16492
Domain	6-blade_b-propeller_TolB-like	NID2 ELP1 TRIM71 NHLRC3 TRIM3 RGN	1.31e-05	46	213	6	IPR011042
Domain	PDZ	MPDZ PDZD7 MAST2 AHNAK MAGI3 PARD3B PRX CASK PDZD2	3.51e-05	141	213	9	PF00595
Domain	PDZ	MPDZ PDZD7 MAST2 AHNAK MAGI3 PARD3B PRX CASK PDZD2	5.14e-05	148	213	9	SM00228
Domain	CA	PCDHB5 FREM2 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3 CELSR3	5.22e-05	115	213	8	SM00112
Domain	-	MPDZ PDZD7 MAST2 AHNAK MAGI3 PARD3B PRX CASK PDZD2	5.70e-05	150	213	9	2.30.42.10
Domain	PDZ	MPDZ PDZD7 MAST2 AHNAK MAGI3 PARD3B PRX CASK PDZD2	6.01e-05	151	213	9	PS50106
Domain	Cadherin	PCDHB5 FREM2 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3 CELSR3	6.27e-05	118	213	8	IPR002126
Domain	PDZ	MPDZ PDZD7 MAST2 AHNAK MAGI3 PARD3B PRX CASK PDZD2	6.32e-05	152	213	9	IPR001478
Domain	Cadherin_2	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3	9.67e-05	65	213	6	PF08266
Domain	Cadherin_N	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3	9.67e-05	65	213	6	IPR013164
Domain	NHL_repeat_subgr	TRIM71 NHLRC3 TRIM3	1.17e-04	9	213	3	IPR013017
Domain	DUF4062	NWD2 TEP1	1.29e-04	2	213	2	PF13271
Domain	DUF4062	NWD2 TEP1	1.29e-04	2	213	2	IPR025139
Domain	FAM21	WASHC2A WASHC2C	1.29e-04	2	213	2	IPR027308
Domain	NHL_repeat	TRIM71 NHLRC3 TRIM3	1.65e-04	10	213	3	IPR001258
Domain	NHL	TRIM71 NHLRC3 TRIM3	1.65e-04	10	213	3	PF01436
Domain	Ig_E-set	PLXNA1 PLXNA3 FLNA FLNB TRIM71 TRIM3 EXOC2	1.89e-04	104	213	7	IPR014756
Domain	Cadherin_CS	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3 CELSR3	2.53e-04	109	213	7	IPR020894
Domain	CADHERIN_1	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3 CELSR3	3.16e-04	113	213	7	PS00232
Domain	Cadherin	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3 CELSR3	3.16e-04	113	213	7	PF00028
Domain	-	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3 CELSR3	3.33e-04	114	213	7	2.60.40.60
Domain	CADHERIN_2	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3 CELSR3	3.33e-04	114	213	7	PS50268
Domain	Cadherin-like	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3 CELSR3	3.71e-04	116	213	7	IPR015919
Domain	NHL	TRIM71 NHLRC3 TRIM3	3.84e-04	13	213	3	PS51125
Domain	CAP-ZIP_m	WASHC2A WASHC2C	3.85e-04	3	213	2	PF15255
Domain	FAM21/CAPZIP	WASHC2A WASHC2C	3.85e-04	3	213	2	IPR029341
Domain	uDENN	DENND2A DENND4A DENND2B	4.85e-04	14	213	3	SM00800
Domain	GPS	ADGRV1 ADGRF5 ADGRL2 CELSR3	5.83e-04	34	213	4	SM00303
Domain	uDENN	DENND2A DENND4A DENND2B	6.01e-04	15	213	3	PF03456
Domain	GPS	ADGRV1 ADGRF5 ADGRL2 CELSR3	6.53e-04	35	213	4	PF01825
Domain	GPS	ADGRV1 ADGRF5 ADGRL2 CELSR3	7.28e-04	36	213	4	PS50221
Domain	UDENN	DENND2A DENND4A DENND2B	7.34e-04	16	213	3	PS50946
Domain	DDENN	DENND2A DENND4A DENND2B	7.34e-04	16	213	3	PS50947
Domain	dDENN	DENND2A DENND4A DENND2B	7.34e-04	16	213	3	SM00801
Domain	DENN	DENND2A DENND4A DENND2B	7.34e-04	16	213	3	SM00799
Domain	DENN	DENND2A DENND4A DENND2B	7.34e-04	16	213	3	PF02141
Domain	dDENN	DENND2A DENND4A DENND2B	7.34e-04	16	213	3	PF03455
Domain	dDENN_dom	DENND2A DENND4A DENND2B	7.34e-04	16	213	3	IPR005112
Domain	uDENN_dom	DENND2A DENND4A DENND2B	7.34e-04	16	213	3	IPR005113
Domain	DENN	DENND2A DENND4A DENND2B	7.34e-04	16	213	3	PS50211
Domain	DENN_dom	DENND2A DENND4A DENND2B	7.34e-04	16	213	3	IPR001194
Domain	GPS	ADGRV1 ADGRF5 ADGRL2 CELSR3	8.09e-04	37	213	4	IPR000203
Domain	CH	MICAL3 CNN2 FLNA FLNB SPECC1	8.72e-04	65	213	5	SM00033
Domain	GPCR_2_extracellular_dom	ADGRV1 ADGRF5 ADGRL2 CELSR3	1.09e-03	40	213	4	IPR001879
Domain	G_PROTEIN_RECEP_F2_1	ADGRV1 ADGRF5 ADGRL2 CELSR3	1.09e-03	40	213	4	PS00649
Domain	G_PROTEIN_RECEP_F2_3	ADGRV1 ADGRF5 ADGRL2 CELSR3	1.09e-03	40	213	4	PS50227
Domain	CH	MICAL3 CNN2 FLNA FLNB SPECC1	1.22e-03	70	213	5	PF00307
Domain	-	MICAL3 CNN2 FLNA FLNB SPECC1	1.30e-03	71	213	5	1.10.418.10
Domain	CH	MICAL3 CNN2 FLNA FLNB SPECC1	1.47e-03	73	213	5	PS50021
Domain	CH-domain	MICAL3 CNN2 FLNA FLNB SPECC1	1.66e-03	75	213	5	IPR001715
Domain	C4	COL4A4 COL4A6	1.88e-03	6	213	2	SM00111
Domain	Collagen_VI_NC	COL4A4 COL4A6	1.88e-03	6	213	2	IPR001442
Domain	NC1_IV	COL4A4 COL4A6	1.88e-03	6	213	2	PS51403
Domain	-	COL4A4 COL4A6	1.88e-03	6	213	2	2.170.240.10
Domain	C4	COL4A4 COL4A6	1.88e-03	6	213	2	PF01413
Domain	Quino_amine_DH_bsu	NID2 TEP1 TRIM3	1.92e-03	22	213	3	IPR011044
Domain	Ion_trans_dom	RYR2 KCNB1 NALCN KCNH2 CNGB1 CNGB3	1.97e-03	114	213	6	IPR005821
Domain	Ion_trans	RYR2 KCNB1 NALCN KCNH2 CNGB1 CNGB3	1.97e-03	114	213	6	PF00520
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	KDM3A ERCC5 CYP2C18 KIF1B GPRIN1 REXO1 TBC1D9 C2CD5 NSFL1C SSH1 MAGED2 FUBP1 MICAL3 NUP153 WDR44 TLK2 MRE11 FLII FLNA ELOA WASHC2C KDM5A YEATS2 KMT2D EXOC2 SPEN	5.23e-12	774	220	26	15302935
Pubmed	Protocadherins.	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3	9.89e-11	13	220	6	12231349
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	TPP2 DENND2A ARHGAP32 CFL1 KIF1B DPYSL5 FKBP9 PSMD2 EPB41L3 SUCLA2 ELFN2 NWD2 DLST MICAL3 TSC22D4 BSN VARS1 CA2 AGAP2 FLII FLNA FLNB DLGAP4 L1CAM ELP1 SPECC1 TRIM3 CASK AGO1 UPF2 PEAK1 UNC13A	5.94e-10	1431	220	32	37142655
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	GGNBP2 DENND4A ERCC5 TRO CFL1 PSMD2 EPB41L3 RYR2 DDX11 MAGED2 FUBP1 AHNAK VPS13A ATP11C DLST BSN VARS1 AGAP2 PLXNA3 FLNA ELOA FLNB KDM5A YBX1 MYH7B MAGI3 APOB PRX ADAMTS12 SCCPDH STS SPEN	7.17e-10	1442	220	32	35575683
Pubmed	The human and murine protocadherin-beta one-exon gene families show high evolutionary conservation, despite the difference in gene number.	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3	2.15e-09	20	220	6	11322959
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ARHGAP32 TCAF1 EPB41L3 ELFN2 REXO1 TBC1D9 C2CD5 PRR12 SSH1 ADGRF5 MICAL3 EXOC7 MAGI3 PRX RAB3GAP1 GLCE SPIDR PEAK1	3.15e-09	493	220	18	15368895
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	TPP2 ARHGAP32 ZNF609 BMS1 PSMD2 GPRIN1 CLCC1 SSH1 PTPRJ GLYR1 AHNAK VPS13A GNL2 MICAL3 ADGRL2 NUP153 ELOA CEP85 ELP1 RAB11FIP1 NCKAP5L CASK KIAA1671 KMT2D SCCPDH PEAK1	3.51e-09	1049	220	26	27880917
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	KDM3A TCAF1 BMS1 MPDZ PSMD2 SUCLA2 DDB2 NSFL1C SUPT6H USP32 GNL2 POLR1B DLST TSC22D4 VARS1 NUP153 CA2 MRE11 FLNA FLNB ACAD9 MAGI3 ICE1 CERT1 CASK	6.69e-09	1005	220	25	19615732
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	DENND4A CFL1 BMS1 PSMD2 CMYA5 EPB41L3 MAST2 SUCLA2 MAGED2 SUPT6H FUBP1 GLYR1 GNL2 DLST MYO18B BSN VARS1 PLXNA1 NUP153 CA2 MRE11 FLII FLNA FLNB YBX1 ACAD9 ELP1 APOB PEAK1 SPEN	8.58e-09	1425	220	30	30948266
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	KIAA0513 CFL1 MAST2 WASHC2A REXO1 TBC1D9 NOD2 PRR12 SSH1 ZFP36L2 KCNH2 AHNAK MICAL3 PLXNA1 PLXNA3 FLII FLNA SZT2 L1CAM ICE1 GRIN2D TEP1 KMT2D CELSR3 CABIN1 SPEN	1.01e-08	1105	220	26	35748872
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ARHGAP32 CFL1 KIF1B HLCS MPDZ PSMD2 EPB41L3 GPRIN1 CLCC1 NSFL1C MAGED2 AHNAK MICAL3 ADGRL2 NUP153 MRE11 FLNB MAGI3 OCRL PEAK1	3.06e-08	708	220	20	39231216
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	CFL1 EPB41L3 GPRIN1 ELFN2 KCNB1 FUBP1 BSN AGAP2 DLGAP4 GRIN2D TRIM3 PEAK1	3.25e-08	231	220	12	16452087
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	ZNF609 EPB41L3 WASHC2A NSFL1C AHNAK POLR1B VARS1 CNN2 TLK2 MRE11 FLII FLNA CEP85 KDM5A OCRL SCCPDH AGO1 UPF2 BRD9 SPEN	4.40e-08	724	220	20	36232890
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	CFL1 FKBP9 ITGA1 PSPH EPB41L3 SUCLA2 CLCC1 MTPN DGLUCY ALDH1L2 AHNAK DLST ALAS1 METTL17 VARS1 PLXNA1 NID2 FLNA ELOA FLNB YBX1 ACAD9 ELP1 CP SCCPDH ASXL3 GLCE CFAP44 ACSL5	4.78e-08	1451	220	29	30550785
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TPP2 ARHGAP32 TCAF1 CFL1 MPDZ EPB41L3 KCNB1 SSH1 MAGED2 BSN NUP153 AGAP2 VGF TLK2 FLII KDM5A DLGAP4 GRIN2D TRIM3 CASK AGO1 CABIN1 UNC13A	5.84e-08	963	220	23	28671696
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	ARHGAP32 KIAA0513 PSMD2 EPB41L3 GPRIN1 SUCLA2 WASHC2A ELFN2 RYR2 NSFL1C KCNB1 GLYR1 DLST BSN VARS1 AGAP2 FLII FLNA FLNB WASHC2C YBX1 DLGAP4 RAB3GAP1 PEAK1 UNC13A	7.57e-08	1139	220	25	36417873
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	NR2C2 BMS1 MPDZ EPB41L3 GPRIN1 SUCLA2 WASHC2A CLCC1 C2CD5 MTPN NSFL1C SUPT6H GLYR1 VPS13A GNL2 DLST ALAS1 IFT80 TSC22D4 ADGRL2 ACAD9 GPAT3 ELP1 RAB11FIP1 NCKAP5L CASK RAB3GAP1 PEAK1 HSPA14	8.03e-08	1487	220	29	33957083
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	PSMD2 CLCC1 MAGED2 SUPT6H DLST EXOC7 VARS1 FLII ELOA WASHC2C ACAD9 ELP1 CASK RAB3GAP1 SCCPDH SUGP1 EXOC2	1.26e-07	560	220	17	35241646
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	ARHGAP32 EPB41L3 MAST2 DSCAML1 IFT80 MAGI3 CELSR3 UNC13A PDZD2	1.56e-07	130	220	9	12421765
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TPP2 KDM3A NR2C2 ZNF609 PCLAF AK6 MTPN PRR12 NSFL1C FUBP1 VARS1 NUP153 TLK2 MRE11 FLNA DDX49 YBX1 TOGARAM2 ZBTB9 YEATS2 KMT2D BRD9 SUGP1 SPEN	1.65e-07	1103	220	24	34189442
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	NR2C2 BMS1 NSFL1C FUBP1 GLYR1 GNL2 NUP153 MRE11 ELOA DDX49 SUGP1 SPEN	2.94e-07	283	220	12	30585729
Pubmed	Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.	CYBB ERCC5 DPYSL5 MPDZ PTPRJ MICAL3 NUP153 MRE11 YBX1 DLGAP4 DOCK10 SPEN	2.94e-07	283	220	12	18854154
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	BMS1 PSMD2 SUCLA2 CLCC1 NSFL1C MAGED2 ALDH1L2 FUBP1 VPS13A GNL2 DLST ALAS1 MTO1 METTL17 SPRYD4 WDR44 FLII CEP85 COL15A1 YBX1 ACAD9 GPAT3 ELP1 OCRL CASK KIAA1671 RAB3GAP1 UPF2	3.15e-07	1496	220	28	32877691
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3 CELSR3	3.83e-07	72	220	7	10380929
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	PSMD2 EPB41L3 GPRIN1 SUCLA2 ELFN2 C2CD5 KCNB1 MICAL3 BSN AGAP2 DLGAP4 L1CAM SPECC1	3.85e-07	347	220	13	17114649
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	ARHGAP32 EPB41L3 GPRIN1 ELFN2 NSFL1C PTPRJ AHNAK ADGRL2 CNN2 MRE11 FLNA FLNB MAGI3 SPECC1 KIAA1671 PEAK1	7.47e-07	565	220	16	25468996
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZNF609 ATP7B HLCS EPB41L3 MAST2 C2CD5 ZNF469 GNL2 MTO1 ADGRL2 MRE11 NID2 KDM5A AOX1 ZBTB9 RAB11FIP1 TEP1 NCKAP5L KIAA1671 YEATS2 BRD9 CSMD1 CLSPN	7.71e-07	1116	220	23	31753913
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3 CELSR3	7.91e-07	80	220	7	10716726
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	MAGED2 VPS13A BSN COL4A4 SZT2 MYH7B DOCK10 SPECC1 YEATS2 SPEN	9.43e-07	208	220	10	33230847
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	KDM3A CFL1 DPYSL5 WASHC2A FUBP1 DLST CNN2 NUP153 FLII FLNA FLNB YBX1 ZBTB9 YEATS2 SUGP1	9.50e-07	506	220	15	30890647
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZNF609 KIF1B DPYSL5 ADGRV1 SUCLA2 DENND2B CLCC1 PTPRJ SUPT6H GLI2 FUBP1 GLYR1 MICAL3 TSC22D4 FLNB MAGI3 PARD3B TEP1 CERT1 CASK KIAA1671 YEATS2 LRRC27 ZFHX2 SPIDR CSMD1 PDZD2	9.59e-07	1489	220	27	28611215
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ZNF609 ATP7B HLCS MPDZ WASHC2A CLCC1 NSFL1C GNL2 POLR1B EXOC7 VARS1 ELOA GPAT3 ICE1 NCKAP5L YEATS2 SUGP1 CLSPN	1.16e-06	733	220	18	34672954
Pubmed	UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.	TPP2 EPB41L3 WASHC2A NSFL1C MAGED2 AHNAK MRE11 FLNA KBTBD4 SUGP1 EXOC2	1.23e-06	267	220	11	33417871
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	BMS1 EPB41L3 WASHC2A AHNAK VARS1 CA2 FLNA FLNB WASHC2C BRD9	1.27e-06	215	220	10	35973513
Pubmed	Human transcription factor protein interaction networks.	NR2C2 ARHGAP32 ZNF609 BMS1 PSMD2 WASHC2A PRR12 MAGED2 GLI2 FUBP1 GLYR1 GNL2 MRE11 CEP85 KDM5A YBX1 ZBTB9 KIAA1671 YEATS2 KMT2D AGO1 BRD9 SUGP1 CABIN1 SPEN RAI2	1.46e-06	1429	220	26	35140242
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3	1.66e-06	57	220	6	32633719
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	TPP2 PNKP PCLAF BMS1 PSMD2 AK6 SUCLA2 CLCC1 NOD2 AHNAK GNL2 DLST MICAL3 EXOC7 ADGRL2 FLNA FLNB YBX1 ACAD9 ELP1 SPECC1 KIAA1671 RAB3GAP1 SCCPDH EXOC2 CABIN1	1.68e-06	1440	220	26	30833792
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TCAF1 ERCC5 WASHC2A C2CD5 MTPN GBP4 ALDH1L2 GLYR1 HPS1 MTO1 METTL17 NUP153 TLK2 MRE11 FLNA FLNB DDX49 WASHC2C ACAD9 APOB XPA PEAK1	1.75e-06	1084	220	22	11544199
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3	1.84e-06	58	220	6	30377227
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	TCAF1 CFL1 BMS1 SUCLA2 MAGED2 GLYR1 AHNAK GNL2 DLST METTL17 VARS1 CNN2 MRE11 FLII FLNA ELOA CEP85 KDM5A YBX1 ELP1 TRIM71 APOB TRIM3 UPF2 HSPA14	2.26e-06	1371	220	25	36244648
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	ARHGAP32 KIF1B DPYSL5 HLCS MAST2 WASHC2A CLCC1 NSFL1C MICAL3 CNN2 WASHC2C MAGI3 CP PARD3B OCRL NCKAP5L KIAA1671 AGO1 CEP41	2.43e-06	853	220	19	28718761
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	KIF1B BMS1 EPB41L3 GPRIN1 CLCC1 RYR2 MAGED2 AHNAK VPS13A ADGRL2 YBX1 APOB OCRL CASK KIAA1671 PEAK1 CLSPN SPEN	2.63e-06	777	220	18	35844135
Pubmed	Identification of a novel cell-adhesive protein spatiotemporally expressed in the basement membrane of mouse developing hair follicle.	FREM2 COL4A4 COL4A6 NID2	2.67e-06	16	220	4	15878328
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	ARHGAP32 TBC1D9 PRR12 FREM2 AHNAK VPS13A ATP11C MICAL3 PLXNA3 COL4A6 SZT2 ADAMTS12 KMT2D ASXL3 ZFHX2	2.76e-06	552	220	15	10737800
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ARHGAP32 DENND4A KIF1B DPYSL5 MPDZ EPB41L3 MAST2 DENND2B ZFP36L2 AHNAK TSC22D4 KDM5A MAGI3 PARD3B RAB11FIP1 NCKAP5L SPECC1 KIAA1671 PEAK1	2.79e-06	861	220	19	36931259
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	NR2C2 ZNF609 EPB41L3 PRR12 AHNAK FLNA FLNB KDM5A ZBTB9 ICE1 KIAA1671 YEATS2 KMT2D	3.04e-06	418	220	13	34709266
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	KDM3A PRR12 NSFL1C SUPT6H NUP153 FLII KDM5A YBX1 SPECC1 CASK KIAA1671 PEAK1	3.74e-06	361	220	12	30344098
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	KDM3A ARHGAP32 TCAF1 MAST2 CLCC1 ADGRF5 ADGRL2	3.83e-06	101	220	7	9872452
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3	4.72e-06	68	220	6	11230163
Pubmed	Defining the membrane proteome of NK cells.	KDM3A PNKP ATP7B CFL1 PSMD2 AK6 ITGA1 CLCC1 MAGED2 AHNAK GNL2 DLST EXOC7 CNN2 AGAP2 FLNA DOCK10 SCCPDH CEP41 EXOC2 HSPA14 ACSL5	5.75e-06	1168	220	22	19946888
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	CFL1 BMS1 PSMD2 EPB41L3 NSFL1C MAGED2 FUBP1 GLYR1 AHNAK POLR1B DLST VARS1 MRE11 FLII FLNA FLNB DDX49 YBX1 DOCK10 ELP1 OCRL RAB3GAP1 UPF2 EXOC2	5.83e-06	1353	220	24	29467282
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	KDM3A NR2C2 ZNF609 PSMD2 EPB41L3 MAGED2 FUBP1 AHNAK TLK2 FLNA WASHC2C YEATS2 SUGP1	5.84e-06	444	220	13	34795231
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	BMS1 DPYSL5 EPB41L3 NWD2 SUPT6H GLYR1 GNL2 DLST VARS1 ELOA DDX49 KDM5A YBX1 TRIM71 CASK AGO1 UPF2 SUGP1 SPEN PIK3R5 UNC13A	6.02e-06	1082	220	21	38697112
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	TPP2 PCLAF CFL1 KIF1B FKBP9 PSMD2 CMYA5 WASHC2A DDB2 MTPN NSFL1C MAGED2 FUBP1 AHNAK VARS1 CNN2 WDR44 MRE11 FLII FLNA FLNB YBX1 ELP1 CERT1 RAB3GAP1	6.37e-06	1455	220	25	22863883
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3	7.74e-06	74	220	6	10817752
Pubmed	Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points.	PLXNA1 PLXNA3 L1CAM	8.58e-06	7	220	3	19063725
Pubmed	A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization.	NID2 COL15A1 ELN	8.58e-06	7	220	3	17324935
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	EPB41L3 VPS13A POLR1B MYO18B FLNA FLNB DLGAP4 GRIN2D PRX CELSR3 SPEN	9.04e-06	329	220	11	17474147
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	TCAF1 PNKP DDB2 MAGED2 GLYR1 AHNAK EXOC7 VARS1 NUP153 MRE11 YBX1 EXOC2	9.05e-06	394	220	12	27248496
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3	9.76e-06	77	220	6	10835267
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NR2C2 ZNF609 CFL1 AK6 EPB41L3 FUBP1 AHNAK GNL2 NUP153 MRE11 FLNA ELOA YBX1 ZBTB9 ICE1 YEATS2 BRD9 SUGP1 SPEN	1.19e-05	954	220	19	36373674
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	KDM3A BMS1 GNL2 ELOA DDX49 MUC19 ZBTB9 YEATS2 SUGP1 CLSPN SPEN	1.19e-05	339	220	11	30415952
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	NR2C2 CFL1 BMS1 HLCS PSMD2 AK6 SUCLA2 NSFL1C FUBP1 AHNAK GNL2 POLR1B VARS1 NUP153 CA2 MRE11 FLNA CEP85 KDM5A YBX1 YEATS2 UPF2 BRD9	1.20e-05	1318	220	23	30463901
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	KDM3A CFL1 MPDZ GPRIN1 AHNAK WDR44 MRE11 FLNA CEP85 KIAA1671 YEATS2 KMT2D PEAK1 SPEN	1.22e-05	549	220	14	38280479
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KIAA0513 TRO KIF1B WASHC2A MICAL3 WASHC2C DLGAP4 DOCK10 HEATR5A YEATS2 SPEN PDZD2	1.25e-05	407	220	12	12693553
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	GGNBP2 ZNF609 PSMD2 CLCC1 C2CD5 ZFP36L2 UCP1 MTO1 TLK2 MRE11 FLNA ELOA CEP85 SZT2 KDM5A ACAD9 YRDC RAB3GAP1 UPF2 GLCE SUGP1 CLSPN HSPA14	1.33e-05	1327	220	23	32694731
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ARHGAP32 GGNBP2 ABCA4 RYR2 VPS13A DLST BSN GPAT3 ELP1 YEATS2 RAB3GAP1 KMT2D ASXL3 SUGP1 SPEN	1.55e-05	638	220	15	31182584
Pubmed	Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia.	EPB41L3 NSFL1C FUBP1 BSN L1CAM TRIM3	1.61e-05	84	220	6	19165527
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ARHGAP32 GPRIN1 C2CD5 MICAL3 ADGRL2 DLGAP4 PARD3B OCRL RAB11FIP1 SPECC1 CASK PEAK1	1.75e-05	421	220	12	36976175
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	PCSK2 FAM185A DPYSL5 ADGRV1 RYR2 KCNB1 HPS1 ADGRL2 NUP153 CEP85 GPAT3 MAGI3 XPA SPECC1 CSMD1 UNC13A PDZD2	1.91e-05	814	220	17	23251661
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	GGNBP2 DENND4A ZNF609 MPDZ MAST2 PRR12 FREM2 MICAL3 EXOC7 DDX11L8 CEP85 DOCK10 ELP1 UPF2 CLSPN	1.92e-05	650	220	15	38777146
Pubmed	Interactome Analysis Reveals Regulator of G Protein Signaling 14 (RGS14) is a Novel Calcium/Calmodulin (Ca2+/CaM) and CaM Kinase II (CaMKII) Binding Partner.	TSC22D4 BSN AGAP2 FLII APOB SPECC1 TRIM3 CASK UNC13A	1.93e-05	233	220	9	29518331
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	TPP2 TCAF1 PNKP EPB41L3 GPRIN1 MAGED2 AHNAK CNN2 FLNA FLNB TRIM3 CASK SCCPDH	1.96e-05	498	220	13	36634849
Pubmed	Xeroderma Pigmentosum	ERCC5 DDB2 XPA	2.04e-05	9	220	3	20301571
Pubmed	The role of neuropilins in cell signalling.	PLXNA1 PLXNA3 L1CAM	2.04e-05	9	220	3	19909241
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	ARHGAP32 CFL1 MPDZ EPB41L3 CLCC1 MTPN MAGED2 FUBP1 AHNAK NUP153 CA2 COL4A4 DOCK10 MAGI3 OCRL CASK KIAA1671 PEAK1	2.43e-05	916	220	18	32203420
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	KDM3A KIF1B HLCS PSMD2 CMYA5 DSCAML1 MTPN DGLUCY USP32 DLST EXOC7 VARS1 AGAP2 FLII FLNB CEP85 KDM5A MAGI3 SPECC1 CASK CELSR3 CABIN1	2.50e-05	1285	220	22	35914814
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	KIF1B WASHC2A DDX11 SUPT6H BSN CEP85 WASHC2C ELP1 NCKAP5L KIAA1671 YEATS2 CLSPN CFAP44 SPEN	2.60e-05	588	220	14	38580884
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	DENND4A KIF1B MPDZ EPB41L3 MAST2 C2CD5 ZFP36L2 CEP85 ELP1 RAB11FIP1 NCKAP5L KIAA1671	3.07e-05	446	220	12	24255178
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	CFL1 HLCS EPB41L3 GPRIN1 MTPN AHNAK GNL2 NUP153 WDR44 MRE11 FLNA ELOA WASHC2C ICE1 OCRL KIAA1671 YEATS2 SUGP1	3.13e-05	934	220	18	33916271
Pubmed	The human and mouse repertoire of the adhesion family of G-protein-coupled receptors.	ADGRV1 ADGRF5 ADGRL2 CELSR3	3.27e-05	29	220	4	15203201
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KDM3A DENND2A ZNF609 PCLAF BMS1 ADGRV1 SUPT6H IFT80 BSN ADGRL2 SZT2 ICE1 CELSR3	3.66e-05	529	220	13	14621295
Pubmed	Severe growth retardation and short life span of double-mutant mice lacking Xpa and exon 15 of Xpg.	ERCC5 XPA	3.98e-05	2	220	2	15661658
Pubmed	Interaction of glutamic-acid-rich proteins with the cGMP signalling pathway in rod photoreceptors.	ABCA4 CNGB1	3.98e-05	2	220	2	10466724
Pubmed	Disruption of the Flnb gene in mice phenocopies the human disease spondylocarpotarsal synostosis syndrome.	FLNA FLNB	3.98e-05	2	220	2	17635842
Pubmed	Phosphorylation of Ser 402 impedes phosphatase activity of slingshot 1.	CFL1 SSH1	3.98e-05	2	220	2	21525957
Pubmed	Control of HIV replication in astrocytes by a family of highly conserved host proteins with a common Rev-interacting domain (Risp).	WASHC2A WASHC2C	3.98e-05	2	220	2	20827171
Pubmed	Involvement of MRE11A and XPA gene polymorphisms in the modulation of DNA double-strand break repair activity: a genotype-phenotype correlation study.	MRE11 XPA	3.98e-05	2	220	2	21880556
Pubmed	The intraflagellar transport protein IFT80 is required for cilia formation and osteogenesis.	GLI2 IFT80	3.98e-05	2	220	2	22771375
Pubmed	FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans.	WASHC2A WASHC2C	3.98e-05	2	220	2	36717248
Pubmed	Filamin depletion blocks endoplasmic spreading and destabilizes force-bearing adhesions.	FLNA FLNB	3.98e-05	2	220	2	21325628
Pubmed	NOD2 is involved in the inflammatory response after cerebral ischemia-reperfusion injury and triggers NADPH oxidase 2-derived reactive oxygen species.	CYBB NOD2	3.98e-05	2	220	2	25892960
Pubmed	Autosomal dominant Alport's syndrome: study of a large Tunisian family.	COL4A4 CERT1	3.98e-05	2	220	2	16970251
Pubmed	XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer.	ERCC5 XPA	3.98e-05	2	220	2	19430706
Pubmed	Wilson's disease: overview.	ATP7B CP	3.98e-05	2	220	2	36697289
Pubmed	Rab11-dependent Recycling of the Human Ether-a-go-go-related Gene (hERG) Channel.	KCNH2 RAB11FIP1	3.98e-05	2	220	2	26152716
Pubmed	Ubiquitin-proteasome-dependent slingshot 1 downregulation in neuronal cells inactivates cofilin to facilitate HSV-1 replication.	CFL1 SSH1	3.98e-05	2	220	2	24418541
Pubmed	Constitutive Gαi coupling activity of very large G protein-coupled receptor 1 (VLGR1) and its regulation by PDZD7 protein.	PDZD7 ADGRV1	3.98e-05	2	220	2	24962568
Pubmed	Spectrum of ATP7B mutations and genotype-phenotype correlation in large-scale Chinese patients with Wilson Disease.	ATP7B CP	3.98e-05	2	220	2	27982432
Pubmed	Muramyl peptides activate innate immunity conjointly via YB1 and NOD2.	NOD2 YBX1	3.98e-05	2	220	2	27694635
Interaction	KCNA3 interactions	ARHGAP32 CFL1 KIF1B HLCS MPDZ PSMD2 EPB41L3 GPRIN1 CLCC1 NSFL1C MAGED2 AHNAK VPS13A MICAL3 BSN ADGRL2 NUP153 COL4A4 MRE11 FLNB SZT2 MYH7B DOCK10 MAGI3 OCRL SPECC1 YEATS2 PEAK1 SPEN	7.50e-08	871	218	29	int:KCNA3
Interaction	NUP43 interactions	KDM3A NR2C2 ZNF609 ERCC5 BMS1 RYR2 ZFP36L2 SUPT6H GLYR1 GNL2 NUP153 FLNA SZT2 KDM5A MUC19 ZBTB9 ICE1 XPA YEATS2 KMT2D SPEN PDZD2	1.28e-06	625	218	22	int:NUP43
Interaction	KCTD13 interactions	TPP2 DENND2A ARHGAP32 CFL1 KIF1B DPYSL5 FKBP9 PSMD2 EPB41L3 SUCLA2 ELFN2 NWD2 NSFL1C DLST MICAL3 TSC22D4 BSN VARS1 CA2 AGAP2 FLII FLNA FLNB DLGAP4 L1CAM ELP1 SPECC1 TRIM3 CASK AGO1 UPF2 PEAK1 UNC13A	1.76e-05	1394	218	33	int:KCTD13
Cytoband	5q31	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3	2.06e-05	115	220	6	5q31
Cytoband	7p11.1	FKBP9 FKBP9P1	2.29e-05	2	220	2	7p11.1
GeneFamily	PDZ domain containing	MPDZ PDZD7 MAST2 AHNAK MAGI3 PARD3B PRX CASK PDZD2	3.38e-06	152	143	9	1220
GeneFamily	Clustered protocadherins	PCDHB5 PCDHB14 PCDHB13 PCDHB10 PCDHB9 PCDHB3	1.13e-05	64	143	6	20
GeneFamily	WD repeat domain containing\|Xeroderma pigmentosum complementation groups\|Nucleotide excision repair	ERCC5 DDB2 XPA	2.64e-05	8	143	3	1125
GeneFamily	Fibronectin type III domain containing\|USH2 complex	PDZD7 ADGRV1	3.69e-04	4	143	2	1244
GeneFamily	WASH complex	WASHC2A WASHC2C	9.13e-04	6	143	2	1331
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	DENND2A DENND4A DENND2B	9.81e-04	25	143	3	504
GeneFamily	Exocyst complex	EXOC7 EXOC2	2.16e-03	9	143	2	1055
GeneFamily	Plexins	PLXNA1 PLXNA3	2.16e-03	9	143	2	683
GeneFamily	Cyclic nucleotide gated channels	CNGB1 CNGB3	2.68e-03	10	143	2	250
GeneFamily	HAD Asp-based non-protein phosphatases	PNKP PSPH	3.26e-03	11	143	2	1045
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA1	PCSK2 PDZD7 MAST2 ADARB2 ELFN2 DDC TBC1D9 C2CD5 NALCN ATP11C VGF PLXNA3 L1CAM OCRL GRM8 ASXL3 ZFHX2 CSMD1 UNC13A	5.69e-07	584	220	19	M39068
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	TCAF1 PDZD7 ADARB2 RYR2 NALCN BSN CNGB1 PLXNA3 PRSS12 L1CAM MUC19 CELSR3 ASXL3 DACT3 ZFHX2 UNC13A	2.24e-06	465	220	16	M39066
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	PDZD7 ADARB2 DSCAML1 RYR2 TBC1D9 C2CD5 NALCN MICAL3 BSN PLXNA1 VGF PLXNA3 PRSS12 L1CAM MUC19 MAGI3 XPA OCRL CERT1 CASK CELSR3 ASXL3 DACT3 ZFHX2 CSMD1 UNC13A	2.29e-06	1106	220	26	M39071
ToppCell	Fetal_29-31_weeks\|World / Lineage, Cell type, age group and donor	DENND2A MPDZ RYR2 MAGED2 GLI2 ADGRL2 NID2 ADAMTS12 ASXL3 ELN	6.08e-08	199	220	10	5b9d355795dd03a22f0961dfd143425c367a4654
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ABCA4 EPB41L3 DSCAML1 IFT80 PLXNA1 COL4A4 NID2 MAGI3 CP HEATR5A	6.37e-08	200	220	10	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	ADGRV1 ADGRF5 ADGRL2 COL4A4 FLNB MAGI3 PARD3B RAB11FIP1 PDZD2	1.81e-07	170	220	9	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HLCS PRR12 POLR1B CNN2 AGAP2 FLNB YRDC CASK YEATS2	2.94e-07	180	220	9	a682a5d55c612709c9ee9fa4289d6f8bef7fe1af
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B NALCN GLI2 ADGRF5 FLNA COL15A1 SPECC1 ELN	3.38e-07	183	220	9	667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DENND2A TCAF1 NALCN KCNH2 GLI2 PRSS12 ADAMTS12 DACT3 ELN	3.70e-07	185	220	9	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	Substantia_nigra-Neuronal-Inhibitory\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	KIAA0513 DPYSL5 TBC1D9 NWD2 KCNH2 BSN L1CAM GRIN2D CELSR3	3.87e-07	186	220	9	9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	DENND2A ITGA1 RYR2 NALCN ADGRL2 COL15A1 ADAMTS12 RGN ELN	4.05e-07	187	220	9	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	CMYA5 MAST2 RYR2 DGLUCY MICAL3 MYO18B ADGRL2 MYH7B SGCG	4.43e-07	189	220	9	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	CMYA5 RYR2 DGLUCY MICAL3 MYO18B ADGRL2 MYH7B SGCG PDZD2	4.43e-07	189	220	9	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 RYR2 NALCN KCNH2 FLNA SGCG AOX1 DACT3 ELN	4.63e-07	190	220	9	562ee3b025c29edf07b8b344323edb49d82f1c7e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 RYR2 NALCN KCNH2 FLNA SGCG AOX1 DACT3 ELN	4.63e-07	190	220	9	f5fb989afabb49d64d91324570cd8c80a4b9e67d
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	CMYA5 RYR2 DGLUCY MICAL3 MYO18B ADGRL2 MYH7B SGCG PDZD2	4.63e-07	190	220	9	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B NALCN GLI2 COL4A4 NID2 COL15A1 SPECC1 ADAMTS12	4.84e-07	191	220	9	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B NALCN GLI2 COL4A4 NID2 COL15A1 SPECC1 ADAMTS12	4.84e-07	191	220	9	8f6d592edc32fdb901af30501d4360512334e8c2
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	CMYA5 MAST2 RYR2 DGLUCY MICAL3 MYO18B ADGRL2 MYH7B SGCG	5.06e-07	192	220	9	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	CMYA5 RYR2 MICAL3 MYO18B ADGRL2 MYH7B SGCG GPAT3 PDZD2	5.51e-07	194	220	9	c3535f7cc0076653c72db582047cff053c322397
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B NALCN GLI2 FLNA COL15A1 SPECC1 ADAMTS12 ELN	5.76e-07	195	220	9	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK2 ARHGAP32 RYR2 KCNB1 VPS13A DPY19L2P1 MAGI3 CSMD1 UNC13A	5.76e-07	195	220	9	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B NALCN GLI2 FLNA COL15A1 SPECC1 ADAMTS12 ELN	5.76e-07	195	220	9	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 NALCN GLI2 COL4A4 NID2 COL15A1 CP ADAMTS12 ELN	5.76e-07	195	220	9	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	PBMC-Control-cDC_3\|Control / Compartment, Disease Groups and Clusters	TBC1D9 ZNF469 GBP4 HPS1 VARS1 KDM5A NHLRC3 SLAMF7 ACSL5	6.01e-07	196	220	9	09d197b321ff9f13c0672ea059c850845b0dbbd5
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABCA4 EPB41L3 DSCAML1 PLXNA1 COL4A4 NID2 MAGI3 CP HEATR5A	6.54e-07	198	220	9	b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP32 ZNF609 ADGRV1 MAGI3 PARD3B CASK SPIDR PEAK1 PDZD2	6.54e-07	198	220	9	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Intermediate\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	PCSK2 DENND2A ABCA4 CMYA5 SSH1 NUP153 PARD3B PRX CABIN1	6.82e-07	199	220	9	cf592d93612023a13de21e0fb8c6b13714f9af71
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A ZFP36L2 GLI2 COL4A4 L1CAM TOGARAM2 ADAMTS12 RAI2	1.29e-06	159	220	8	330ecbba97d47bc818a5e8d1d84b05d056bd831e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A ZFP36L2 GLI2 COL4A4 L1CAM TOGARAM2 ADAMTS12 RAI2	1.29e-06	159	220	8	cbb331eb689d8cea9e1146ba85e0a05d23301c47
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	DENND2A ITGA1 RYR2 COL4A6 COL15A1 ADAMTS12 DACT3 ELN	1.36e-06	160	220	8	fd14dfeb7021a4b7299371854dc8fc1fd66c8dae
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DENND2A ADARB2 DDC VGF COL15A1 DOCK10 MAGI3 CP	1.71e-06	165	220	8	c6b23013d77fa9aa967b76e451c8e42b0a657c30
ToppCell	Control-B_intermediate-1\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ERCC5 WASHC2A AHNAK MRE11 ELOA WASHC2C ELP1 ICE1	1.87e-06	167	220	8	948504367ecf58144d9dd74d2ec531358fc4b309
ToppCell	390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ITGA1 GBP4 ADGRF5 ADGRL2 CA2 AGAP2 PRX CLSPN	2.14e-06	170	220	8	a6fa0cab1fa829ec601fe48306b4c43c83425b04
ToppCell	390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ITGA1 GBP4 ADGRF5 ADGRL2 CA2 AGAP2 PRX CLSPN	2.14e-06	170	220	8	b40255eee45eb18b5a297336d7f3845fd8f8aa3b
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	DENND2A ITGA1 ADARB2 RYR2 ADGRL2 NID2 GRM8 RGN	2.23e-06	171	220	8	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	ITGA1 RYR2 KCNH2 MICAL3 COL4A6 FLNA L1CAM ELN	2.33e-06	172	220	8	c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf
ToppCell	droplet-Fat-Bat-18m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK2 POLR1B COL4A4 NID2 COL15A1 PCDHB14 CP CSMD1	2.65e-06	175	220	8	b4f01e7782cdd107d0817ef601891fd3a382bc35
ToppCell	droplet-Fat-Bat-18m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK2 POLR1B COL4A4 NID2 COL15A1 PCDHB14 CP CSMD1	2.65e-06	175	220	8	7f7598d46d10bff1cbea42f950bdde1aaa16e9a4
ToppCell	droplet-Fat-Bat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK2 POLR1B COL4A4 NID2 COL15A1 PCDHB14 CP CSMD1	2.65e-06	175	220	8	ef6f811d8e1839f405c3b41090ddf79be57a099f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B GLI2 COL4A4 COL15A1 PCDHB13 ELN UNC13A	2.77e-06	176	220	8	9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B GLI2 COL4A4 COL15A1 PCDHB13 ELN UNC13A	2.77e-06	176	220	8	3f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B COL4A4 COL15A1 PCDHB10 SPECC1 ADAMTS12 ELN	3.01e-06	178	220	8	d4ecb84e9b1f4ec49c519321156aa10f9bd34cce
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	ADGRV1 ALS2CL ADGRF5 COL4A4 MAGI3 PARD3B RAB11FIP1 PDZD2	3.14e-06	179	220	8	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PCSK2 DPYSL5 GPRIN1 NWD2 CNGB1 L1CAM CELSR3 UNC13A	3.14e-06	179	220	8	af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGA1 RYR2 NALCN COL4A6 COL15A1 AOX1 APOB ELN	3.40e-06	181	220	8	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	Epithelial-lung_neuroendocrine_cell_(PNEC)\|World / Lineage, Cell type, age group and donor	PCSK2 DDC DSCAML1 NALCN KCNH2 BSN VGF UNC13A	3.55e-06	182	220	8	57bf4ffb304324e2e392e196336a530d9f78fe0d
ToppCell	LA-07._Pericyte\|World / Chamber and Cluster_Paper	DENND2A ITGA1 DSCAML1 ADGRF5 AGAP2 SPECC1 ADAMTS12 PDZD2	3.69e-06	183	220	8	e3835db4795362b0442d5893baf2a78efcc20428
ToppCell	PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PCSK2 DPYSL5 GPRIN1 CNGB1 VGF L1CAM DOCK10 CELSR3	3.69e-06	183	220	8	9dfb398b9995d562864fe688861a831ada0814cd
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 ADGRV1 DSCAML1 RYR2 FREM2 APOB ASXL3 CSMD1	3.84e-06	184	220	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 ADGRV1 DSCAML1 RYR2 FREM2 APOB ASXL3 CSMD1	3.84e-06	184	220	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2 FREM2 ATP11C CA2 COL4A4 PRSS12 DOCK10 GRIN2D	3.84e-06	184	220	8	e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 ADGRV1 DSCAML1 RYR2 FREM2 APOB ASXL3 CSMD1	3.84e-06	184	220	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2 FREM2 ATP11C CA2 COL4A4 TOGARAM2 DOCK10 PARD3B	4.16e-06	186	220	8	77592a6397b44b2b59a4fc39d7224dd95343efe6
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CYBB ADGRV1 RYR2 AHNAK COL4A6 MUC19 UPF2 CSMD1	4.16e-06	186	220	8	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	RV-07._Pericyte\|RV / Chamber and Cluster_Paper	DENND2A ITGA1 DSCAML1 ADGRF5 AGAP2 SPECC1 ADAMTS12 PDZD2	4.16e-06	186	220	8	c533b264fbe12bc35467486fc7fbde24ba968fe1
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPB41L3 KCNH2 NID2 P2RY12 L1CAM PCDHB14 ADAMTS12 CSMD1	4.33e-06	187	220	8	8e8b147258982b359447add5027318f5b6d51963
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2 FREM2 ATP11C CA2 COL4A4 PRSS12 DOCK10 PARD3B	4.51e-06	188	220	8	8268574584e5fb869a6cb8bbd7135cd7454a6a25
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 RYR2 NALCN GLI2 FLNA SPECC1 DACT3 ELN	4.51e-06	188	220	8	b2d68a32314e9b099ed74d974079ad96359d1ae3
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A ADGRV1 DSCAML1 PTPRJ MICAL3 CP GRM8 CASK	4.69e-06	189	220	8	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ITGA1 DENND2B ADGRF5 ADGRL2 GRM8 PRX KIAA1671 SMAD6	4.69e-06	189	220	8	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A ADGRV1 DSCAML1 PTPRJ MICAL3 CP GRM8 CASK	4.69e-06	189	220	8	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 RYR2 NALCN KCNH2 FLNA SPECC1 DACT3 ELN	4.87e-06	190	220	8	2e88e366d377d74deb53a4ea870973ce5c6532e8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 RYR2 NALCN KCNH2 FLNA SPECC1 DACT3 ELN	4.87e-06	190	220	8	0028f886c789ba238c031eae5d96acaed4af8c25
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	CMYA5 RYR2 DGLUCY MYO18B ADGRL2 MYH7B SGCG PDZD2	4.87e-06	190	220	8	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	Globus_pallidus-Neuronal\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	DPYSL5 GPRIN1 RYR2 BSN VGF L1CAM CELSR3 UNC13A	4.87e-06	190	220	8	416de85d8841dac883faa6f5339b2fb461a09e82
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ITGA1 DENND2B ADGRF5 ADGRL2 GRM8 PRX KIAA1671 SMAD6	4.87e-06	190	220	8	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B NALCN GLI2 NID2 COL15A1 ADAMTS12 DACT3	5.06e-06	191	220	8	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Artery\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TDRD10 FLNB GRM8 SPECC1 KIAA1671 MSX1 CSMD1 SMAD6	5.06e-06	191	220	8	4b3d5157344dbfbf4fab518611cd9fa37fac7bd9
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A ITGA1 RYR2 GLI2 AOX1 PARD3B ADAMTS12 ELN	5.06e-06	191	220	8	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	CMYA5 RYR2 DGLUCY MYO18B ADGRL2 MYH7B SGCG PDZD2	5.06e-06	191	220	8	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	CMYA5 RYR2 MICAL3 MYO18B ADGRL2 MYH7B SGCG GPAT3	5.06e-06	191	220	8	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	FKBP9 MICAL3 CNN2 CP ADAMTS12 DACT3 ELN PEAK1	5.06e-06	191	220	8	e7c605b56934d1383237c1f946dbccef25d91368
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B RYR2 GLI2 FLNA COL15A1 ELN UNC13A	5.06e-06	191	220	8	04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B NALCN GLI2 NID2 COL15A1 ADAMTS12 DACT3	5.06e-06	191	220	8	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RYR2 KCNB1 GLI2 MYO18B FLNA DACT3 ELN CSMD1	5.26e-06	192	220	8	bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RYR2 KCNB1 GLI2 MYO18B FLNA DACT3 ELN CSMD1	5.26e-06	192	220	8	b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A ITGA1 RYR2 GLI2 AOX1 PARD3B ADAMTS12 ELN	5.26e-06	192	220	8	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRO RYR2 KCNB1 BSN VGF L1CAM CSMD1 UNC13A	5.47e-06	193	220	8	8689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRO RYR2 KCNB1 BSN VGF L1CAM CSMD1 UNC13A	5.47e-06	193	220	8	be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRO RYR2 KCNB1 BSN VGF L1CAM CSMD1 UNC13A	5.47e-06	193	220	8	0c652ebe22ce5d2927599dd97ef1920547858395
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B NALCN GLI2 COL4A4 COL15A1 ADAMTS12 ELN	5.68e-06	194	220	8	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B NALCN GLI2 FLNA COL15A1 ADAMTS12 ELN	5.90e-06	195	220	8	edd4cd8402af81737b2074f9dce71cc6ab09be7e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 RYR2 NALCN GLI2 FLNA COL15A1 SPECC1 ELN	6.12e-06	196	220	8	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B NALCN GLI2 COL15A1 CP SPECC1 ADAMTS12	6.12e-06	196	220	8	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 RYR2 NALCN GLI2 FLNA COL15A1 SPECC1 ELN	6.12e-06	196	220	8	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF609 ADGRV1 PTPRJ MAGI3 PARD3B CASK SPIDR PDZD2	6.12e-06	196	220	8	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	FKBP9 MAGED2 MICAL3 CNN2 CP DACT3 ELN PEAK1	6.12e-06	196	220	8	54f4cf778f95a9ff662e5c7520916a25e605bf95
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B NALCN GLI2 FLNA COL15A1 ADAMTS12 ELN	6.12e-06	196	220	8	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B NALCN GLI2 FLNA COL15A1 ADAMTS12 ELN	6.12e-06	196	220	8	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A ITGA1 RYR2 GLI2 AOX1 PARD3B ADAMTS12 ELN	6.12e-06	196	220	8	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B GLI2 COL4A4 COL15A1 SPECC1 ADAMTS12 ELN	6.35e-06	197	220	8	09946ee8dfb15a2a32da06e5b331f3277ee934f4
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B GLI2 COL4A4 NID2 COL15A1 ADAMTS12 PEAK1	6.35e-06	197	220	8	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	COPD-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	ITGA1 WASHC2A GBP4 ADGRF5 ADGRL2 WASHC2C PRX SMAD6	6.35e-06	197	220	8	30dbc05ea66892d2e18ff375ffa86d1db7bc4083
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B GLI2 COL4A4 NID2 COL15A1 ADAMTS12 PEAK1	6.35e-06	197	220	8	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	(2)_5-FU-(3)_LEPR+_perivascular_cells\|World / Stress and Cell class	FKBP9 MPDZ DENND2B MAGED2 AHNAK CNN2 NID2 FLNA	6.35e-06	197	220	8	434ae0231972acba12d06279908cf407e70511ac
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 DENND2B NALCN GLI2 FLNA COL15A1 SPECC1 ADAMTS12	6.35e-06	197	220	8	80e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	PDZD7 DDX11 SUPT6H AHNAK NID2 FLNA YEATS2 SLAMF7	6.59e-06	198	220	8	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A ITGA1 RYR2 GLI2 AOX1 PARD3B ADAMTS12 ELN	6.59e-06	198	220	8	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABCA4 EPB41L3 DSCAML1 IFT80 COL4A4 MAGI3 CP HEATR5A	6.84e-06	199	220	8	a270630626df614f8605abddb7dee7c4d74f6149
ToppCell	Tracheal\|World / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP32 HLCS CMYA5 ADARB2 ALDH1L2 GLI2 CP ERN2	7.10e-06	200	220	8	682960e28542a3d6c119047cd0131941932cfdea
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP32 HLCS ADGRV1 ADARB2 PTPRJ FLNB ERN2 KIAA1671	7.10e-06	200	220	8	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DENND2A TCAF1 ITGA1 CMYA5 NALCN KCNH2 FLNA PRSS12	7.10e-06	200	220	8	09537dc25f8b8b4654a7c183827ee1522a41a4e0
Computational	Actin cytoskeleton binding.	CFL1 CNN2 FLII FLNA FLNB	3.70e-05	30	139	5	MODULE_524
Computational	Genes in the cancer module 419.	CFL1 CNN2 FLII FLNA FLNB	6.92e-05	34	139	5	MODULE_419
Drug	aspirin, USP; Down 200; 100uM; HL60; HT_HG-U133A	DGLUCY ZFP36L2 HPS1 EXOC7 FLII OCRL RAB3GAP1 BRD9 SUGP1 CABIN1 CFAP44	3.18e-06	197	217	11	1145_DN
Drug	Zoxazolamine [61-80-3]; Down 200; 23.8uM; MCF7; HT_HG-U133A	ZNF609 MAST2 DENND2B ZFP36L2 HPS1 VGF AOX1 TEP1 ERN2 STS CNGB3	3.34e-06	198	217	11	5390_DN
Drug	Methamphetamine	CYBB ZNF609 PCLAF DPYSL5 ITGA1 MAST2 ALS2CL REXO1 MTPN KCNB1 SUPT6H AHNAK DLST ADGRF5 MICAL3 IFT80 MYO18B EXOC7 VGF FLNA FLNB WASHC2C YBX1 ELP1 ICE1 GRIN2D CERT1 BRD9 CSMD1 CABIN1 PIK3R5 ACSL5	3.88e-06	1401	217	32	ctd:D008694
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A	ZNF609 HLCS ZFP36L2 SUPT6H GLYR1 FLII NID2 KDM5A TEP1 STS	1.72e-05	193	217	10	4338_DN
Drug	PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A	ALS2CL DENND2B RYR2 ZFP36L2 FUBP1 TSC22D4 EXOC7 SZT2 DLGAP4 SUGP1	1.80e-05	194	217	10	4559_DN
Drug	Prenylamine lactate [69-43-2]; Down 200; 9.6uM; PC3; HT_HG-U133A	ZNF609 ATP7B KIAA0513 MICAL3 EXOC7 TRIM3 STS SPIDR CFAP44 SMAD6	1.88e-05	195	217	10	5070_DN
Drug	Methazolamide [554-57-4]; Up 200; 17uM; MCF7; HT_HG-U133A	HLCS PSPH KCNH2 GLYR1 EXOC7 PLXNA1 DLGAP4 CNGB3 SUGP1 CABIN1	1.88e-05	195	217	10	6268_UP
Drug	Guaifenesin [93-14-1]; Up 200; 20.2uM; MCF7; HT_HG-U133A	ARHGAP32 HLCS RYR2 SSH1 GLYR1 HPS1 FLII ERN2 GLCE SPIDR	2.05e-05	197	217	10	3431_UP
Drug	Ginkgolide A [15291-75-5]; Up 200; 9.8uM; HL60; HT_HG-U133A	ZNF609 PIPOX MAST2 NOD2 ZFP36L2 TEP1 ERN2 TRIM3 SLAMF7 SMAD6	2.05e-05	197	217	10	1324_UP
Drug	Piperine [94-62-2]; Up 200; 14uM; HL60; HT_HG-U133A	CYBB ZNF609 DGLUCY GLYR1 HPS1 SZT2 DLGAP4 TEP1 ERN2 SUGP1	2.05e-05	197	217	10	1327_UP
Drug	Acetaminophen [103-90-2]; Up 200; 26.4uM; PC3; HT_HG-U133A	AHNAK HPS1 TSC22D4 PLXNA3 DOCK10 TEP1 ERN2 STS SUGP1 UNC13A	2.05e-05	197	217	10	6284_UP
Drug	Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; HL60; HT_HG-U133A	ZNF609 MAGED2 TSC22D4 PLXNA1 FLII ELOA TEP1 ERN2 CASK SUGP1	2.15e-05	198	217	10	1859_UP
Drug	Dubinidine [22964-77-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A	TPP2 MPDZ PSPH MAGED2 SUPT6H EXOC7 VGF DDX49 RAB3GAP1 SMAD6	2.15e-05	198	217	10	6250_DN
Drug	Nadolol [42200-33-9]; Down 200; 13uM; PC3; HT_HG-U133A	HLCS MAST2 ALS2CL TBC1D9 ZFP36L2 HPS1 ADGRF5 GRM8 CNGB3 RAI2	2.15e-05	198	217	10	4021_DN
Drug	Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; PC3; HT_HG-U133A	ZNF609 KCNB1 HPS1 ADGRL2 AGAP2 COL15A1 TRIM3 STS CNGB3 CABIN1	2.15e-05	198	217	10	4273_UP
Drug	(R)-Propranolol hydrochloride [13071-11-9]; Down 200; 13.6uM; MCF7; HT_HG-U133A	ZNF609 PSPH MAST2 DENND2B SUPT6H HPS1 CEP85 KDM5A ERN2 CNGB3	2.15e-05	198	217	10	3553_DN
Drug	Chlorhexidine [55-56-1]; Up 200; 8uM; PC3; HT_HG-U133A	EXOC7 VGF FLNA KDM5A ADAMTS12 CELSR3 SUGP1 ELN CFAP44 ACSL5	2.15e-05	198	217	10	6302_UP
Drug	Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; PC3; HT_HG-U133A	ALS2CL MICAL3 TSC22D4 ERN2 TRIM3 SCCPDH KBTBD4 SUGP1 CABIN1 SPEN	2.15e-05	198	217	10	1825_DN
Drug	Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; HL60; HT_HG-U133A	ZNF609 PIPOX MAST2 MAGED2 TSC22D4 VGF CELSR3 CNGB3 SUGP1 SMAD6	2.24e-05	199	217	10	2392_UP
Drug	AC1L1KJQ	NOD2 AOX1 ELN SPEN	7.34e-05	24	217	4	CID000005529
Drug	cyclopenta-2,4-diene-1-carbaldehyde;cyclopentane;iron	SGCG CP	9.04e-05	2	217	2	CID011986719
Drug	irosustat	CA2 STS	9.04e-05	2	217	2	ctd:C520511
Drug	NSC-333488	AOX1 ELN	9.04e-05	2	217	2	CID000100082
Drug	NSC353638	UCP1 HPS1 CP	9.75e-05	10	217	3	CID000094414
Drug	Fenoterol hydrobromide [1944-12-3]; Down 200; 10.4uM; HL60; HT_HG-U133A	ARHGAP32 ALS2CL MICAL3 PLXNA1 CA2 FLNB ERN2 BRD9 CABIN1	9.86e-05	192	217	9	2378_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A	PIPOX ALS2CL ZFP36L2 AGAP2 VGF SGCG TEP1 STS SUGP1	1.07e-04	194	217	9	3969_DN
Drug	Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A	ZNF609 ATP7B MAST2 PLXNA3 KDM5A AOX1 TEP1 TRIM3 STS	1.07e-04	194	217	9	3303_DN
Drug	PF-01378883-00 [351320-41-7]; Up 200; 10uM; PC3; HT_HG-U133A	TRO GLI2 HPS1 ADGRL2 VGF STS CEP41 ELN SLAMF7	1.07e-04	194	217	9	6368_UP
Drug	Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A	DENND4A PIPOX PSPH ZFP36L2 KCNH2 EXOC7 ERN2 CASK CNGB3	1.07e-04	194	217	9	5303_UP
Drug	Skimmianine [83-95-4]; Down 200; 15.4uM; HL60; HT_HG-U133A	DENND4A KIF1B PDZD7 TBC1D9 NSFL1C GNL2 EXOC7 FLII CFAP44	1.07e-04	194	217	9	2504_DN
Drug	Sulindac [38194-50-2]; Up 200; 11.2uM; HL60; HT_HG-U133A	KIAA0513 HLCS MAGED2 TSC22D4 PLXNA1 FLNA SUGP1 ELN SMAD6	1.11e-04	195	217	9	1857_UP
Drug	(R)-Propranolol hydrochloride [13071-11-9]; Down 200; 13.6uM; PC3; HT_HG-U133A	MPDZ SSH1 SUPT6H MICAL3 CNN2 DDX49 ERN2 YEATS2 SUGP1	1.11e-04	195	217	9	5814_DN
Drug	SC 19220; Up 200; 10uM; MCF7; HT_HG-U133A	ALS2CL DENND2B GLYR1 SZT2 STS CNGB3 ELN PEAK1 CABIN1	1.11e-04	195	217	9	7060_UP
Drug	Metyrapone [54-36-4]; Up 200; 17.6uM; HL60; HT_HG-U133A	ATP7B KIAA0513 TBC1D9 SUPT6H COL4A6 GRM8 TRIM3 STS GLCE	1.15e-04	196	217	9	3070_UP
Drug	Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A	ZNF609 MAST2 AGAP2 VGF SZT2 AOX1 ELP1 ERN2 SUGP1	1.15e-04	196	217	9	4359_DN
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; HL60; HT_HG-U133A	NSFL1C ZFP36L2 EXOC7 PLXNA1 FLII FLNB CASK SCCPDH SUGP1	1.15e-04	196	217	9	2361_DN
Drug	Stachydrine hydrochloride; Down 200; 22.2uM; PC3; HT_HG-U133A	DENND2A HLCS ZFP36L2 SUPT6H TSC22D4 PLXNA3 KDM5A ERN2 CABIN1	1.15e-04	196	217	9	4469_DN
Drug	N-hydroxy-AABP	ERCC5 DDB2 AOX1 STS	1.19e-04	27	217	4	CID000020527
Drug	estradiol, USP; Down 200; 0.1uM; HL60; HT_HG-U133A	PIPOX RYR2 AHNAK PRSS12 ERN2 GRM8 SUGP1 ELN UNC13A	1.20e-04	197	217	9	2668_DN
Drug	Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A	DDC RYR2 KCNH2 GNA15 AOX1 LAG3 ZFHX2 PEAK1 PIK3R5	1.20e-04	197	217	9	5242_UP
Drug	AH23848 hemicalcium salt hydrate; Up 200; 1uM; MCF7; HT_HG-U133A	HLCS MAST2 ALS2CL NOD2 KCNH2 GLYR1 HPS1 STS SUGP1	1.20e-04	197	217	9	6890_UP
Drug	Metyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A	DENND2A ZNF609 KIAA0513 MAST2 EXOC7 FLII CEP85 SZT2 SPIDR	1.20e-04	197	217	9	4606_DN
Drug	Perphenazine [58-39-9]; Down 200; 10uM; MCF7; HT_HG-U133A	DENND4A ZNF609 ZFP36L2 SUPT6H VGF AOX1 ERN2 SPIDR SMAD6	1.20e-04	197	217	9	1540_DN
Drug	Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; HL60; HT_HG-U133A	ZNF609 PIPOX HLCS TBC1D9 UCP1 TEP1 TRIM3 SUGP1 SLAMF7	1.20e-04	197	217	9	2380_UP
Drug	Ricinine [524-40-3]; Up 200; 24.4uM; PC3; HT_HG-U133A	DENND2A PIPOX ZFP36L2 HPS1 MRE11 SZT2 GRM8 TRIM3 PRX	1.20e-04	197	217	9	5725_UP
Drug	Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; PC3; HT_HG-U133A	ZNF609 RYR2 ZFP36L2 GLYR1 AHNAK HPS1 ADGRF5 GRM8 TRIM3	1.25e-04	198	217	9	6698_UP
Drug	Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A	PSPH ALS2CL RYR2 ZFP36L2 GLYR1 HPS1 MICAL3 ELP1 SUGP1	1.25e-04	198	217	9	5289_UP
Drug	SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A	ZNF609 SUPT6H AGAP2 SZT2 DOCK10 ELP1 TEP1 CABIN1 UNC13A	1.25e-04	198	217	9	4977_UP
Drug	Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; PC3; HT_HG-U133A	PIPOX FUBP1 AHNAK AGAP2 GRM8 TRIM3 CNGB3 SLAMF7 UNC13A	1.25e-04	198	217	9	3725_UP
Drug	Clonidine hydrochloride [4205-91-8]; Up 200; 15uM; MCF7; HT_HG-U133A	MAST2 RYR2 AGAP2 MRE11 SZT2 TEP1 GRM8 TRIM3 PIK3R5	1.25e-04	198	217	9	3172_UP
Drug	Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A	ALS2CL RYR2 ZFP36L2 VGF SGCG AOX1 ERN2 RAB3GAP1 SUGP1	1.25e-04	198	217	9	3311_DN
Drug	Sulfathiazole [72-14-0]; Up 200; 15.6uM; HL60; HG-U133A	ARHGAP32 PDZD7 MAST2 NSFL1C MAGED2 PLXNA1 MRE11 DDX49 CERT1	1.25e-04	198	217	9	1963_UP
Drug	Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; HL60; HT_HG-U133A	ZNF609 MAST2 SUPT6H GLYR1 TSC22D4 EXOC7 DDX49 TEP1 GLCE	1.25e-04	198	217	9	1320_UP
Drug	Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A	NOD2 TSC22D4 COL4A6 MRE11 KDM5A DLGAP4 GRM8 SPIDR CFAP44	1.25e-04	198	217	9	6819_UP
Drug	Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; HL60; HG-U133A	NSFL1C GLYR1 DLGAP4 ERN2 ADAMTS12 KBTBD4 SUGP1 SPIDR CABIN1	1.25e-04	198	217	9	1719_UP
Drug	Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A	RYR2 SZT2 PRSS12 DOCK10 OCRL GRM8 STS ELN SPIDR	1.29e-04	199	217	9	5048_UP
Drug	Trolox [53188-07-1]; Down 200; 16uM; MCF7; HT_HG-U133A	ALS2CL HPS1 KDM5A ELP1 TRIM3 CASK STS CELSR3 SUGP1	1.29e-04	199	217	9	2883_DN
Drug	Cephalothin sodium salt [58-71-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	HLCS ZFP36L2 GLYR1 TSC22D4 EXOC7 DLGAP4 TEP1 SUGP1 CABIN1	1.29e-04	199	217	9	6079_DN
Drug	Melatonin [73-31-4]; Down 200; 17.2uM; PC3; HT_HG-U133A	TPP2 MAST2 POLR1B EXOC7 KDM5A DLGAP4 STS SUGP1 CABIN1	1.34e-04	200	217	9	6293_DN
Drug	chlorpromazine hydrochloride; Down 200; 1uM; HL60; HT_HG-U133A	MPDZ PDZD7 PSPH MAGED2 STS KBTBD4 SUGP1 ELN PIK3R5	1.34e-04	200	217	9	2677_DN
Drug	CP-320650-01 [172079-28-6]; Down 200; 10uM; PC3; HT_HG-U133A	CYBB ZFP36L2 UCP1 TSC22D4 ADGRL2 VGF COL4A6 ELP1 TRIM3	1.34e-04	200	217	9	3822_DN
Drug	Tranexamic acid [1197-18-8]; Up 200; 25.4uM; PC3; HT_HG-U133A	DENND2A TRO AHNAK TSC22D4 NID2 LAG3 PRX CEP41 ACSL5	1.34e-04	200	217	9	5762_UP
Disease	myopathy (implicated_via_orthology)	COL4A4 COL4A6 FLNA FLNB COL15A1 MYH7B	1.26e-06	48	213	6	DOID:423 (implicated_via_orthology)
Disease	hydrocephalus (is_implicated_in)	MPDZ L1CAM TRIM71	7.30e-06	6	213	3	DOID:10908 (is_implicated_in)
Disease	alcohol use disorder (implicated_via_orthology)	PCSK2 KDM3A CFL1 PSPH RYR2 SSH1 KDM5A BRD9 UNC13A	1.31e-05	195	213	9	DOID:1574 (implicated_via_orthology)
Disease	Xeroderma pigmentosum	ERCC5 DDB2 XPA	3.02e-05	9	213	3	cv:C0043346
Disease	Malignant neoplasm of breast	KDM3A ABCA4 ATP7B CFL1 HLCS EPB41L3 ALS2CL MAGED2 TSC22D4 AGAP2 MRE11 NID2 FLNA FLNB YBX1 ELP1 GRIN2D KMT2D CLSPN SPEN HSPA14	3.71e-05	1074	213	21	C0006142
Disease	Usher syndrome, type 2C	PDZD7 ADGRV1	5.19e-05	2	213	2	C2931213
Disease	USHER SYNDROME, TYPE IIC	PDZD7 ADGRV1	5.19e-05	2	213	2	605472
Disease	Juvenile macular degeneration	ABCA4 CNGB3	5.19e-05	2	213	2	C4282180
Disease	Usher syndrome type 2C	PDZD7 ADGRV1	5.19e-05	2	213	2	cv:C2931213
Disease	Usher syndrome type 2C (is_implicated_in)	PDZD7 ADGRV1	5.19e-05	2	213	2	DOID:0110839 (is_implicated_in)
Disease	cryptorchidism (biomarker_via_orthology)	KDM5A MSX1 STS	5.86e-05	11	213	3	DOID:11383 (biomarker_via_orthology)
Disease	Basal cell carcinoma	ERCC5 DDB2 XPA	5.86e-05	11	213	3	C0007117
Disease	FG syndrome (is_implicated_in)	FLNA CASK	1.55e-04	3	213	2	DOID:14711 (is_implicated_in)
Disease	meningioma (is_marker_for)	EPB41L3 KMT2D	1.55e-04	3	213	2	DOID:3565 (is_marker_for)
Disease	myofibrillar myopathy 5 (implicated_via_orthology)	FLNA FLNB	1.55e-04	3	213	2	DOID:0080096 (implicated_via_orthology)
Disease	distal muscular dystrophy 4 (implicated_via_orthology)	FLNA FLNB	1.55e-04	3	213	2	DOID:0111190 (implicated_via_orthology)
Disease	FG SYNDROME 4 (disorder)	FLNA CASK	1.55e-04	3	213	2	C1845546
Disease	FG SYNDROME 2	FLNA CASK	1.55e-04	3	213	2	C1845902
Disease	Warsaw breakage syndrome (implicated_via_orthology)	DDX11 DDX11L8	1.55e-04	3	213	2	DOID:0060535 (implicated_via_orthology)
Disease	FG SYNDROME 3	FLNA CASK	1.55e-04	3	213	2	C1845567
Disease	FG syndrome	FLNA CASK	1.55e-04	3	213	2	C0220769
Disease	hair colour measurement	ADGRV1 DDB2 DDX11 FREM2 ZNF469 AHNAK PLXNA1 FLII MYH7B DLGAP4 DOCK10 ADAMTS12 KMT2D EXOC2	1.66e-04	615	213	14	EFO_0007822
Disease	epilepsy (implicated_via_orthology)	KCNH2 BSN L1CAM GRIN2D GRM8 SLC13A5 UNC13A	1.90e-04	163	213	7	DOID:1826 (implicated_via_orthology)
Disease	FG syndrome	FLNA CASK	3.08e-04	4	213	2	cv:C0220769
Disease	hydantoin-5-propionate measurement	AOX1 AMDHD1	3.08e-04	4	213	2	EFO_0800051
Disease	phospholipids in very small VLDL measurement	COX19 APOB CERT1 SUGP1	5.06e-04	51	213	4	EFO_0022300
Disease	Malignant Cystosarcoma Phyllodes	FLNA KMT2D	5.11e-04	5	213	2	C0600066
Disease	Phyllodes Tumor	FLNA KMT2D	5.11e-04	5	213	2	C0010701
Disease	aortic valve stenosis (is_implicated_in)	APOB ELN	5.11e-04	5	213	2	DOID:1712 (is_implicated_in)
Disease	STARGARDT DISEASE 1 (disorder)	ABCA4 CNGB3	5.11e-04	5	213	2	C1855465
Disease	p-tau measurement, cerebrospinal fluid biomarker measurement	ADGRL2 DDX49	5.11e-04	5	213	2	EFO_0004763, EFO_0006794
Disease	monocyte count	DENND4A PCLAF KIF1B PSMD2 ADGRV1 MAST2 DDB2 DENND2B POLR1B DLST ADGRF5 GNA15 VARS1 CNN2 FLNB SZT2 DOCK10 ELN SPIDR SLAMF7 CABIN1	6.16e-04	1320	213	21	EFO_0005091
Disease	nephrotic syndrome (biomarker_via_orthology)	CFL1 DDC APOB	6.71e-04	24	213	3	DOID:1184 (biomarker_via_orthology)
Disease	pallidum volume change measurement, age at assessment	TBC1D9 GRM8 CSMD1	7.59e-04	25	213	3	EFO_0008007, EFO_0021494
Disease	larynx cancer (is_implicated_in)	ERCC5 NOD2	7.63e-04	6	213	2	DOID:2596 (is_implicated_in)
Disease	xeroderma pigmentosum (is_implicated_in)	DDB2 XPA	7.63e-04	6	213	2	DOID:0050427 (is_implicated_in)
Disease	Stargardt's disease	ABCA4 CNGB3	7.63e-04	6	213	2	C0271093
Disease	Disorder of eye	ABCA4 PDZD7 ADGRV1 FREM2 CNGB1 CNGB3 CEP41	9.19e-04	212	213	7	C0015397
Disease	tumor necrosis factor ligand superfamily member 6, soluble form measurement	BSN CELSR3	1.06e-03	7	213	2	EFO_0020797
Disease	Strabismus	ADARB2 EXOC2 CSMD1	1.18e-03	29	213	3	HP_0000486
Disease	brain aneurysm	PCSK2 ARHGAP32 HLCS PARD3B PDZD2	1.40e-03	113	213	5	EFO_0003870
Disease	cerebrovascular disease (is_implicated_in)	P2RY12 GLCE	1.41e-03	8	213	2	DOID:6713 (is_implicated_in)
Disease	uridine measurement	ABCA4 NALCN CSMD1	1.58e-03	32	213	3	EFO_0010546
Disease	epilepsy (is_implicated_in)	KCNB1 CP	1.81e-03	9	213	2	DOID:1826 (is_implicated_in)
Disease	response to simvastatin, PCSK9 protein measurement	CNGB3 CFAP44	1.81e-03	9	213	2	EFO_0006899, GO_1903491
Disease	abdominal aortic aneurysm (implicated_via_orthology)	P2RY12 ELN	1.81e-03	9	213	2	DOID:7693 (implicated_via_orthology)
Disease	Inflammatory Bowel Diseases	NOD2 HPS1 MUC19	2.05e-03	35	213	3	C0021390
Disease	colon cancer (is_implicated_in)	KDM3A MRE11 PIK3R5	2.22e-03	36	213	3	DOID:219 (is_implicated_in)
Disease	response to carboplatin, response to antineoplastic agent	FLNB CSMD1	2.25e-03	10	213	2	GO_0097327, GO_0097328
Disease	ovarian carcinoma	KDM3A ABCA4 ADGRV1 ADARB2 NUP153 SGCG PARD3B ASXL3	2.42e-03	321	213	8	EFO_0001075
Disease	hepatocyte growth factor-like protein measurement	ALS2CL BSN CELSR3	2.60e-03	38	213	3	EFO_0008154
Disease	rheumatoid arthritis, Crohn's disease	NOD2 BSN MAGI3	2.60e-03	38	213	3	EFO_0000384, EFO_0000685
Disease	pulmonary hypertension (biomarker_via_orthology)	CYBB RYR2 ALAS1 SMAD6	2.72e-03	80	213	4	DOID:6432 (biomarker_via_orthology)
Disease	Long QT Syndrome	RYR2 KCNH2	2.73e-03	11	213	2	C0023976
Disease	cholesterol in very small VLDL measurement	COX19 APOB SUGP1	3.01e-03	40	213	3	EFO_0022231
Disease	Cutaneous Melanoma	ERCC5 DDB2 XPA	3.23e-03	41	213	3	C0151779
Disease	craniosynostosis (is_implicated_in)	FLNA SMAD6	3.26e-03	12	213	2	DOID:2340 (is_implicated_in)
Disease	collagen disease (implicated_via_orthology)	COL4A4 COL4A6	3.26e-03	12	213	2	DOID:854 (implicated_via_orthology)
Disease	cleft palate (is_implicated_in)	FLNB MSX1	3.26e-03	12	213	2	DOID:674 (is_implicated_in)
Disease	colorectal health	ADGRV1 RYR2 DDX11 KCNB1 GLYR1 CSMD1	3.50e-03	201	213	6	EFO_0008460
Disease	liver fat measurement	SUGP1 ZFHX2 SPEN	3.70e-03	43	213	3	EFO_0010821
Disease	nasopharynx carcinoma (is_marker_for)	KDM3A FUBP1 SPEN	3.70e-03	43	213	3	DOID:9261 (is_marker_for)
Disease	Fatty Liver	ATP7B APOB STS SLC13A5	3.84e-03	88	213	4	C0015695
Disease	Steatohepatitis	ATP7B APOB STS SLC13A5	3.84e-03	88	213	4	C2711227
Disease	reticulocyte count	DENND4A FKBP9 PSMD2 ITGA1 MAST2 DENND2B ZNF469 PTPRJ ZFP36L2 AHNAK USP32 VPS13A BSN FLNB SPECC1 PDZD2	3.97e-03	1045	213	16	EFO_0007986
Disease	total lipids in very small VLDL measurement	COX19 APOB SUGP1	4.21e-03	45	213	3	EFO_0022156
Disease	esophagus squamous cell carcinoma (is_implicated_in)	EPB41L3 KMT2D SPEN	4.21e-03	45	213	3	DOID:3748 (is_implicated_in)
Disease	reticulocyte measurement	DENND4A FKBP9 PSMD2 ITGA1 DENND2B ZNF469 PTPRJ ZFP36L2 AHNAK USP32 VPS13A BSN FLNA FLNB SPECC1 PDZD2	4.27e-03	1053	213	16	EFO_0010700
Disease	revision of total hip arthroplasty	ICE1 ADAMTS12	4.46e-03	14	213	2	EFO_0020973
Disease	eating disorder, bipolar disorder	RYR2 NALCN	4.46e-03	14	213	2	EFO_0005203, MONDO_0004985
Disease	GDH/6PGL endoplasmic bifunctional protein measurement	OVCH1 SUGP1	4.46e-03	14	213	2	EFO_0801619
Disease	Neurodevelopmental Disorders	PARD3B CERT1 CASK ASXL3	4.67e-03	93	213	4	C1535926
Disease	free cholesterol in very small VLDL measurement	COX19 APOB SUGP1	4.76e-03	47	213	3	EFO_0022275
Disease	end stage renal disease (biomarker_via_orthology)	CYBB CYP2C18 DDC	4.76e-03	47	213	3	DOID:783 (biomarker_via_orthology)
Disease	fasting blood glucose measurement	DPYSL5 MTPN ADGRL2 VARS1 ELP1 AGO1 CSMD1	5.01e-03	287	213	7	EFO_0004465
Disease	autism spectrum disorder (implicated_via_orthology)	ARHGAP32 DSCAML1 KDM5A DLGAP4 CASK	5.02e-03	152	213	5	DOID:0060041 (implicated_via_orthology)
Disease	ovarian carcinoma (is_implicated_in)	L1CAM CABIN1	5.12e-03	15	213	2	DOID:4001 (is_implicated_in)
Disease	low density lipoprotein triglyceride measurement	APOB SUGP1	5.12e-03	15	213	2	EFO_0009946
Disease	Colorectal Carcinoma	PCSK2 ABCA4 ATP7B ADARB2 DSCAML1 ZFP36L2 VPS13A ATP11C COL4A6 APOB PIK3R5 ACSL5	5.24e-03	702	213	12	C0009402
Disease	phospholipids in medium LDL measurement	ITGA1 APOB CERT1	5.35e-03	49	213	3	EFO_0022183
Disease	severe acute respiratory syndrome, COVID-19	PSMD2 SUCLA2 ADARB2 REXO1 GLI2 CASK ADAMTS12 CSMD1 PDZD2	5.42e-03	447	213	9	EFO_0000694, MONDO_0100096
Disease	T-Cell Lymphoma	KMT2D ASXL3	5.82e-03	16	213	2	C0079772
Disease	nervousness	PTPRJ DLST	5.82e-03	16	213	2	NCIT_C74532
Disease	Early infantile epileptic encephalopathy with suppression bursts	PNKP CASK	5.82e-03	16	213	2	C0393706
Disease	Pheochromocytoma, Extra-Adrenal	KIF1B DDC	5.82e-03	16	213	2	C1257877
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	APOB CERT1 SUGP1	5.99e-03	51	213	3	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	total lipids in medium LDL	ITGA1 APOB CERT1	6.32e-03	52	213	3	EFO_0022180
Disease	total lipids in LDL measurement	ITGA1 APOB CERT1	6.32e-03	52	213	3	EFO_0022308
Disease	venous thromboembolism	DPYSL5 DDB2 MTPN PTPRJ ADGRL2 TOGARAM2 PARD3B TRIM71 KBTBD4	6.49e-03	460	213	9	EFO_0004286
Disease	Astrocytosis	ITGA1 GRM8	6.57e-03	17	213	2	C3887640
Disease	phosphatidylcholine 40:6 measurement	NOD2 CSMD1	6.57e-03	17	213	2	EFO_0010389
Disease	Gliosis	ITGA1 GRM8	6.57e-03	17	213	2	C0017639
Disease	Familial thoracic aortic aneurysm and aortic dissection	FLNA ELN SMAD6	6.66e-03	53	213	3	C4707243
Disease	total phospholipids in lipoprotein particles measurement	COX19 APOB SUGP1	6.66e-03	53	213	3	EFO_0022315
Disease	free cholesterol in small LDL measurement	ITGA1 APOB CERT1	6.66e-03	53	213	3	EFO_0022271

Protein segments in the cluster

Peptide	Gene	Start	Entry
GGVGLKKTFLEKSPD	UNC13A	1476	Q9UPW8
GKGKVTFPNGFTLEG	ALS2CL	541	Q60I27
ALSGPKGEKGSVGFV	COL4A6	891	Q14031
EKLGGSAVISLEGKP	CFL1	151	P23528
SVGLSGFAIEFKEKP	CSMD1	1546	Q96PZ7
KKAVSLLSPVAFGFG	ABCA4	791	P78363
SKLLPGFTTLGFKDE	BRD9	361	Q9H8M2
GGKFPVDGKVLEGNT	ATP7B	836	P35670
KTDVAAPFGGVKQSG	ALDH1L2	886	Q3SY69
FGGVTNGKPEDKLGI	ACAD9	251	Q9H845
AGDGKKPSITAVVGS	AGO1	601	Q9UL18
PRGIKSLKGEAITDG	ADGRV1	1446	Q8WXG9
SGGLKVLAQKFPEGL	CEP41	251	Q9BYV8
PGEKGEKGNSVFILG	COL4A4	166	P53420
FQTGSLLKGKAFLPG	C17orf78	121	Q8N4C9
KSLIKSFDLGRPGGA	SPECC1	821	Q5M775
VKGPSIALLGFSKGG	ACOT6	221	Q3I5F7
TGPSLEGDLGLKGAK	AHNAK	376	Q09666
VPKFSVSGAKGEETG	AHNAK	436	Q09666
LEGPKVKGSLGATGE	AHNAK	5456	Q09666
VKGSLGATGEIKGPT	AHNAK	5461	Q09666
SKFAGGLHFSGPKVE	AHNAK	5611	Q09666
IQDFKFPLGIKGAGS	ADGRL2	681	O95490
KFISGIFTKSTGGPP	AGAP2	346	Q99490
VTRKLGEGFKSLEPG	GLCE	426	O94923
IGGVKLKAIPSDGNF	DDC	201	P20711
PGKTIKVKTFLPGAG	DENND2B	841	P78524
KEKLVYAPLSGVGGV	BMS1	331	Q14692
GPVGGFLKLSSRKDG	CFAP44	1301	Q96MT7
FTKAPSLEGTAGKVG	DLGAP4	151	Q9Y2H0
NTRIGDGTFFKIPGK	ASXL3	61	Q9C0F0
KEGSGYVDIGLIPKG	ADAMTS12	711	P58397
VSLLGSAPGGKVEFK	AOX1	501	Q06278
KTSAGPCFVGLLGEK	NWD2	111	Q9ULI1
LEGSLSKFALPGKSE	DENND4A	1411	Q7Z401
AVPTIFCGKIKGLSG	RAI2	446	Q9Y5P3
GNSLGKPLEKGIFTS	RAB3GAP1	41	Q15042
FILTSPDGAGTGKVI	NR2C2	51	P49116
GDSGAGEFKFLKPII	PCDHB5	756	Q9Y5E4
EVNGLTFEGTGPTKK	ADARB2	161	Q9NS39
VKGFFGGLETKLKGP	KIAA0513	241	O60268
TPGVGKTTLGKELAS	AK6	11	Q9Y3D8
VTPKGINGIDFKGEA	CERT1	231	Q9Y5P4
GFLGPIIKAETGDKV	CP	91	P00450
AGGSGTNEFKFLKPI	PCDHB13	756	Q9Y5F0
LKKGPEGLGFTVVTR	PARD3B	386	Q8TEW8
SKENSAPVKLGGFGV	CASK	151	O14936
LEVEKSALGGGKLPG	DPY19L2P1	31	Q6NXN4
KGIAKQTPFSGLGLI	PRSS12	216	P56730
VGDGIKSLEPGRKSF	PTPRJ	701	Q12913
LSGKEAKGPLQDGAT	MICAL3	836	Q7RTP6
AFRTGKLLKGGEPDL	GNL2	426	Q13823
SNKLDFDGLPSGIGK	FLII	301	Q13045
GAFAPLTKATGDGLK	TRIM71	481	Q2Q1W2
DAGILGTTKDSPKLG	MAGED2	356	Q9UNF1
LIKGPKGFGFAIADS	MAGI3	581	Q5TCQ9
LFETTKSGPALGKAV	KIAA1671	146	Q9BY89
AALGKLKTGPEGALG	NCKAP5L	666	Q9HCH0
GPDSGKGAKSLVELL	GGNBP2	616	Q9H3C7
VKTDGGDPSGLLKNF	ALAS1	156	P13196
FIVPTGKTGLIIGKG	FUBP1	381	Q96AE4
EKLGFVVGRLKTGTP	MTO1	226	Q9Y2Z2
IREDGGTLGVFSPKK	KIF1B	516	O60333
GKISFNPKDVLGRGA	ERN2	516	Q76MJ5
APLKFGLDIKSSGSG	FAM185A	146	Q8N0U4
FPDVISKGVSLKEGG	FREM2	1421	Q5SZK8
GLGGPSIKDKYVTAL	KCNH2	601	Q12809
FSKILPGGAAEQAGK	BSN	3896	Q9UPA5
GPKVSIVGLDDSGFL	HLCS	681	P50747
EPLEKLGFGDLTSGK	COX19	71	Q49B96
QGDASKVTAKGPGLE	FLNB	351	O75369
KVFGPGVERSGLKAN	FLNB	746	O75369
GKPAEFTIDTKGAGT	FLNB	1056	O75369
FAIVAALGDGPGKKA	MYH7B	236	A7E2Y1
ALGDGPGKKAQFLAT	MYH7B	241	A7E2Y1
GQAKLFVGTPIDGKS	PLXNA1	181	Q9UIW2
GPSKLFVGTAVDGKS	PLXNA3	161	P51805
GGRGTSTVSFKLLKP	EXOC2	81	Q96KP1
AQVASGKGKLAPGFD	FKBP9P1	91	Q75LS8
GKGKLAPGFDAELIV	FKBP9P1	96	Q75LS8
TGAFKVLDPEGKGTI	MYLPF	101	Q96A32
FFSLGLGAPGKAEDK	MUC19	106	Q7Z5P9
GFKIAGITSAPGKQA	MUC19	7221	Q7Z5P9
FQPGGAVEKESLGKL	PDZD2	1171	O15018
GGKSSVTGDGPLVIK	PDZD2	2766	O15018
LDGEAAKVGAKQGPS	PDZD7	826	Q9H5P4
PKGAVDDAIAFGGKT	PEAK1	1126	Q9H792
GSITPTDKKIGFLGL	GLYR1	261	Q49A26
FKALGEEKGGASLSP	L1CAM	1051	P32004
TLPGASKLLGVGTKY	GBP4	621	Q96PP9
KSGILEAAGFPDPGK	GLI2	16	P10070
PTVKLGAVGGSGFKV	ELP1	461	O95163
KSFGSPGSLGKLLCE	LAG3	356	P18627
LLLGPGESGKSTFIK	GNA15	46	P30679
CLTGGPGTSEFKFLK	PCDHB10	756	Q9UN67
TFPFKILSDAKLGTG	P2RY12	76	Q9H244
FGIKDKPTFIKGIGA	DDB2	141	Q92466
KPTFIKGIGAGGSIT	DDB2	146	Q92466
AGKIGIFESPTGTGK	DDX11	36	Q96FC9
IPSGGDGKTLKFFGQ	ITGA1	621	P56199
KAFTGEGQKLGSTAP	NSFL1C	251	Q9UNZ2
SDPGKTGLLSVAEGK	ARHGAP32	1796	A7KAX9
FTKPDKISGVIGAAA	GRM8	141	O00222
LGYLPGKGTGSLLKS	KDM5A	146	P29375
GLDGKKGGSNLIPLE	EXOC7	286	Q9UPT5
QIPEEAGSSGLGKAK	PCLAF	81	Q15004
KEGTSLGEVGGPDLK	NID2	366	Q14112
GGKVEGGTPLFTLRK	DLST	131	P36957
VASGKGKLAPGFDAE	FKBP9	521	O95302
PVKVTALGGGKLEAT	OBP2B	51	Q9NPH6
TGGSGTNEFKFLKPI	PCDHB14	756	Q9Y5E9
SGVIAPGAKAGVKLE	APOB	851	P04114
FLFEASTGKPLGDGK	IFT80	441	Q9P2H3
LGQLGLKEGFPSAVK	ICE1	2176	Q9Y2F5
GKDTGGLVPGKSLVF	HEATR5A	1666	Q86XA9
GDIYPKTLLGKIVGG	KCNB1	381	Q14721
GTGDLKILTEPKGSC	KDM3A	376	Q9Y4C1
ILKLLGKPDSGVGAE	CABIN1	1271	Q9Y6J0
GAGAPAGPAKVFVKI	DACT3	591	Q96B18
TPFTLSGKKHGGVAE	DOCK10	1981	Q96BY6
GKTILVKNFLPGSGT	DENND2A	711	Q9ULE3
QEKFGTGGAAVPEKI	ELOA	706	Q14241
KKGSFEIGGTIHPVA	GPAT3	316	Q53EU6
GKAPAKIISFGGTVT	DSCAML1	1286	Q8TD84
GPGPADASKVVAKGL	FLNA	2551	P21333
PVLTKVGKGELGSGL	CMYA5	1386	Q8N3K9
VLPEAKKAPGSGAVF	CEP85	221	Q6P2H3
AGKIGIFESPTGTGK	DDX11L8	36	A8MPP1
DVLPSFAAKLGVKGS	ACSL5	591	Q9ULC5
SLVVGKDGFIKAIGP	AMDHD1	41	Q96NU7
SVLSGKGALPGKGVL	MAST2	1456	Q6P0Q8
KLPKIAVDGPFGTAS	CYBB	381	P04839
AKTGSGKTAAFVLPI	DDX49	46	Q9Y6V7
GRGSFPVAEKVNKGL	CYP2C18	96	P33260
AAKKIPGISSTGVGD	DGLUCY	466	Q7Z3D6
LGGAQGPSKDKVAVL	CELSR3	1616	Q9NYQ7
GGKGDPLSSEKAGLV	GPRIN1	516	Q7Z2K8
GKAETKLPGQEGAAA	GPRIN1	636	Q7Z2K8
LASGKGEPVSLGKAD	GPRIN1	681	Q7Z2K8
SSELGKGPLAAFVKT	HPS1	566	Q92902
GEGSVAGSKSPVFKA	C4orf54	886	D6RIA3
SPELITFHGVKGEKG	COL15A1	976	P39059
KAAAKFGAGAAGVLP	ELN	261	P15502
GKAKELPGSQVIFEG	SLC13A5	176	Q86YT5
AEVFSKTVAGGLPGA	RYR2	1311	Q92736
LAEKLLKGGSESGEP	METTL17	226	Q9H7H0
SGSAGKEGGPFKALL	C2CD5	321	Q86YS7
AAQPAFTGIKGKEGS	EPB41L3	881	Q9Y2J2
GGAKVIDATGKLVIP	DPYSL5	46	Q9BPU6
TGGSGTNEFKFLKPI	PCDHB3	756	Q9Y5E6
KGAPNADLIFKTGGR	UPF2	1256	Q9HAU5
SPTGKSNILVFKLGG	HSPA14	186	Q0VDF9
TGGSETGEFKFLKPI	PCDHB9	756	Q9Y5E1
EAPFLVGIEGSLKGS	OIP5	116	O43482
ATKFALRGLGKGFVP	VARS1	956	P26640
GAPSLKDLGGTGIKA	SZT2	1171	Q5T011
EKGLSGLTTLFPGQK	REXO1	646	Q8N1G1
FTLPKKEGLSFLGGL	RAB11FIP1	291	Q6WKZ4
KFGEGVSSPKTHLGE	VGF	246	O15240
GVKYGLVGLEPTKVA	SPRYD4	51	Q8WW59
KIGFGILLSKEPDGV	SMAD6	386	O43541
FTGGLGQLVVPSKAK	TSC22D4	166	Q9Y3Q8
GGVFTPGAAFSKTKL	SCCPDH	396	Q8NBX0
TGHKVLFTVGKLGPF	TCAF1	271	Q9Y4C2
EASGVKEKGLDLPGS	TOGARAM2	186	Q6ZUX3
PSKDVHKGVGGIIFS	LRRC27	31	Q9C0I9
PLGVKVEDSAFGKPA	MSX1	11	P28360
DVVGQAGKPKTITGF	PSMD2	851	Q13200
APLVLEKASGEGFGK	TDRD10	121	Q5VZ19
VPGKDAIYSLGGKTL	KBTBD4	326	Q9NVX7
GPGKKLIASFAGTLA	OVCH1	1046	Q7RTY7
GLKVRDGKGIPFTAT	ERCC5	431	P28715
ILVATKDGLKLGSGP	PTTG3P	16	Q9NZH4
KPGEGSVFTTGFKRL	STS	171	P08842
GTVRKESGIPSGKFE	TRGV9	76	Q99603
VKPQGKVAGFDLDGT	PNKP	161	Q96T60
PEAGGIFKITGLGVK	RGN	276	Q15493
KIKLSVPKAGEGLGT	PRR12	1226	Q9ULL5
KGSTKIALYGLGSIP	MRE11	171	P49959
LDTKDKPSVFSGLLG	OCRL	136	Q01968
FESGLKGGVKIVFSP	SUCLA2	111	Q9P2R7
GTDKLRVTGPEGALF	SGCG	161	Q13326
KLEFGSPKGRSGSLL	SSH1	571	Q8WYL5
LEARFTGVGVSKGPL	TLK2	16	Q86UE8
ILPGFKGVTVTGFKS	ADGRF5	211	Q8IZF2
AVLGIFLKVGSAKPG	CA2	141	P00918
TFVTEPLKHIGKGTG	CLCC1	306	Q96S66
IGKAVGFLSVPKSLS	CLSPN	706	Q9HAW4
GGPDGKSVLVTLKAG	CNGB1	1011	Q14028
ETPKLFKTLLGGTGK	CNGB3	671	Q9NQW8
IGPDFQKGLKDGTIL	CNN2	46	Q99439
KNLKGSPITLSIGDG	ATP11C	806	Q8NB49
LGYEKGKPVGLVGVT	SUGP1	421	Q8IWZ8
GLDGLAKKFGLTPEQ	SUPT6H	531	Q7KZ85
GKETAPSLGSKILAG	UCP1	106	P25874
FVSGITGIVTKPIKG	VPS13A	2971	Q96RL7
GLTSAAPAGGDKKVI	YBX1	41	P67809
TEKKGPDTSGFISGL	ZFHX2	1306	Q9C0A1
PKFNLLLGKVDDGTG	ZFHX2	1941	Q9C0A1
GLKVTKDLGAPGASI	TEP1	1831	Q99973
IAGYIGDKKLEPSGI	MPDZ	391	O75970
KILPKRGSEGGVAAF	SPEN	36	Q96T58
GADKTVKGPDGLTAF	MTPN	91	P58546
SLGFLVRAKGVVPGS	NOD2	581	Q9HC29
FGDLVQVLGTPGKKG	NHLRC3	141	Q5JS37
PTAESGGKGKVIKLL	PSPH	151	P78330
GEKAGFPGVLDTAKP	PIK3R5	261	Q8WYR1
AGILGTTKDTPKLGL	TRO	521	Q12816
PGAGLKVLFTKETAG	SPIDR	336	Q14159
FGLSGPKVAKAEAEG	PRX	936	Q9BXM0
VGKLFVAQPAKEGGS	TBC1D9	1066	Q6ZT07
AGGLVAAIAPKGSEK	ZNF609	131	O15014
GTLTEAFPVLGGKAI	TPP2	716	P29144
GSPGKVGLSTFKETE	WDR44	26	Q5JSH3
GKKIPAGAVSVFLGD	WASHC2C	401	Q9Y4E1
GSVGGAVTFPLKSKV	SLAMF7	31	Q9NQ25
TGTLGFGDKFKRPIG	NUP153	781	P49790
LGDPGQGTVALKKGE	MYO18B	221	Q8IUG5
GPGVAKSKDGILGLQ	ZNF469	1881	Q96JG9
TQPGGAKEETKVFSG	ZBTB9	301	Q96C00
NVKAAPKIIDTGGGF	XPA	61	P23025
GKKIPAGAVSVFLGD	WASHC2A	401	Q641Q2
FSGHGFKLAPVVGKI	PIPOX	346	Q9P0Z9
PEALKKGVSSGKGYI	TRMT10B	296	Q6PF06
KQGDSSLVFGIKPGD	POLR1B	786	Q9H9Y6
LKEPSGGGGTALLNK	ZFP36L2	101	P47974
KVPTEKGATGLSNLG	USP32	726	Q8NFA0
GGLGAFTKVIIKQEP	YEATS2	581	Q9ULM3
SPEGKFKTKIGAGRL	TRIM3	561	O75382
LGSTVVDLSVPGKFG	YRDC	236	Q86U90
GLEAGLDTPKVATKG	ELFN2	486	Q5R3F8
KKGPAAQAEVLSGDG	KMT2D	1711	O14686
GPGKKLGSLVVFTAS	NALCN	501	Q8IZF0
GGAALVLTPKEKGST	GRIN2D	146	O15399
ELGFVGSAPQKGVLK	PCSK2	571	P16519